Management ChangeJun 23, 2026, 08:36 AM
Myriad Genetics Director Daniel Skovronsky Resigns
AI Summary
Myriad Genetics, Inc. announced that Daniel M. Skovronsky, M.D., Ph.D., a member of its Board of Directors, resigned from his position, effective immediately on June 17, 2026. The company clarified that Dr. Skovronsky's departure was not a result of any disagreement with its operations, policies, or practices.
Key Highlights
- Daniel M. Skovronsky resigned from Myriad Genetics' Board of Directors.
- Resignation was effective immediately on June 17, 2026.
- Resignation was not due to any disagreement with the company's operations, policies, or practices.
- Dr. Skovronsky held the position of a director on the Board.
Price Impact
More from MYGN